SCHEMBL2376299

SCHEMBL2376299

OC(O)c1ccc(C(O)O)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
TAAR1 Q96RJ0 4/20 0.35
HIF1A Q16665 2/20 0.35
HTR3A P46098 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
TDP1 Q9NUW8 4/20 0.33
KDM4E B2RXH2 3/20 0.33
APEX1 P27695 3/20 0.33
ALOX15 P16050 1/20 0.33
UGT2B7 P16662 1/20 0.32
LMNA P02545 3/20 0.32
PGK1 P00558 2/20 0.32
PGK2 P07205 2/20 0.32
MAPK1 P28482 2/20 0.32
BLM P54132 3/20 0.31
MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL118557 0.86 ESR1 (0.55) ESR1ESR2PDCD1CD274TAAR1
SCHEMBL16582103 0.83 IDO1 (0.38)
SCHEMBL21708803 0.83 TPMT (0.38)
SCHEMBL15581117 0.83 NOS3 (0.48) ESR1ESR2PDCD1CD274HIF1A
SCHEMBL3085137 0.83 CYP2A6 (0.50) TSHRALOX15MAPK1ALDH1A1
SCHEMBL3403037 0.83 MAPT (0.50) HIF1ATSHRTDP1KDM4EAPEX1
SCHEMBL44352 0.83 ACHE (0.50) TDP1LMNAALDH1A1SMN1; SMN2
SCHEMBL1494552 0.83 TYR (0.48) ESR1ESR2PDCD1CD274HIF1A
SCHEMBL7563025 0.83 IDO1 (0.46) KDM4ELMNAALDH1A1SMN1; SMN2
SCHEMBL10654649 0.83 TSHR (0.50) HIF1ATSHRTDP1APEX1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024241157-A1 COMPOSITIONS FOR PROLONGING THE SHELF LIFE OF A FOOD PRODUCT, PROCESS FOR PRODUCING THE COMPOSITIONS, USES THEREOF Agree NET S.r.l. (IT) 2024-11-28 WO disclosed
EP-4464162-A1 COMPOSITIONS FOR EXTENDING THE SHELF LIFE OF A FOOD PRODUCT, METHOD FOR PRODUCING THE COMPOSITIONS, USES THEREOF Agree NET S.r.l. (IT) 2024-11-20 EP disclosed
US-9978474-B2 Conductive open frameworks THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-05-22 US disclosed
US-20170279109-A1 LITHIUM METAL OXIDE COMPOSITES, AND METHODS FOR PREPARING AND USING THEREOF NIVO SYSTEMS, INC. 2017-09-28 US disclosed
US-20170279109-A1 LITHIUM METAL OXIDE COMPOSITES, AND METHODS FOR PREPARING AND USING THEREOF NIVO SYSTEMS, INC. 2017-09-28 US disclosed
US-20170222217-A1 CARBON-ENRICHED OPEN FRAMEWORK COMPOSITES, METHODS FOR PRODUCING AND USING SUCH COMPOSITES NIVO SYSTEMS, INC. (US) 2017-08-03 US disclosed
US-20170222217-A1 CARBON-ENRICHED OPEN FRAMEWORK COMPOSITES, METHODS FOR PRODUCING AND USING SUCH COMPOSITES NIVO SYSTEMS, INC. (US) 2017-08-03 US disclosed
US-9598442-B2 Crystallized hybrid solid having a three-dimensional DMOF-1-N3 organic-inorganic matrix and method for preparing the same IFP Energies Nouvelles (FR) 2017-03-21 US disclosed
US-20170012277-A1 OPEN FRAMEWORK COMPOSITES, METHODS FOR PRODUCING AND USING SUCH COMPOSITES NIVO SYSTEMS, INC. (US) 2017-01-12 US disclosed
US-20160247593-A1 CONDUCTIVE OPEN FRAMEWORKS UNITED STATES DEPARTMENT OF ENERGY 2016-08-25 US disclosed
US-20100286022-A1 EDIBLE AND BIOCOMPATIBLE METAL-ORGANIC FRAMEWORKS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-11-11 US disclosed
EP-1335944-B1 CATALYST SYSTEM, CONTAINING CATALYSTS ENCAPSULATED IN WAX BASF SE (DE) 2008-07-23 EP disclosed
US-20050209353-A1 Method for producing polyurethane foamed materials having an improved long-term stability BASF AKTIENGESELLSCHAFT (DE) 2005-09-22 US disclosed
EP-1511785-A1 METHOD FOR PRODUCING POLYURETHANE FOAMED MATERIALS HAVING AN IMPROVED LONG-TERM STABILITY BASF AKTIENGESELLSCHAFT (DE) 2005-03-09 EP disclosed
US-20050004403-A1 Method for producing polyether alcohols BASF AKTIENGESELLSCHAFT (DE) 2005-01-06 US disclosed
EP-1448665-A1 METHOD FOR PRODUCING POLYETHER ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2004-08-25 EP disclosed
WO-2003099895-A1 METHOD FOR PRODUCING POLYURETHANE FOAMED MATERIALS HAVING AN IMPROVED LONG-TERM STABILITY BASF AKTIENGESELLSCHAFT (DE) 2003-12-04 WO disclosed
WO-2003085021-A1 CATALYST SYSTEMS CONTAINING CATALYSTS THAT ARE EMBEDDED IN WAX BASF AKTIENGESELLSCHAFT (DE) 2003-10-16 WO disclosed
WO-2003042281-A1 METHOD FOR PRODUCING POLYETHER ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2003-05-22 WO disclosed
US-4169821-A CONTAINING CARBOXYLIC GROUPS ESTERIFIED WITH POLYHYDRIC ALCOHOLS HOECHST AKTIENGESELLSCHAFT (DE) 1979-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160247593-A1 CONDUCTIVE OPEN FRAMEWORKS GJB2, OR10J3, EPCAM ESR1 1186/4885ESR2 3476/4885PDCD1 1206/4885
US-20100286022-A1 EDIBLE AND BIOCOMPATIBLE METAL-ORGANIC FRAMEWORKS CD68, CD63, FABP2 ESR1 1821/4885ESR2 3367/4885PDCD1 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.